WO2005115092A3 - Micronized oral pharmaceutical composition - Google Patents

Micronized oral pharmaceutical composition Download PDF

Info

Publication number
WO2005115092A3
WO2005115092A3 PCT/IN2005/000177 IN2005000177W WO2005115092A3 WO 2005115092 A3 WO2005115092 A3 WO 2005115092A3 IN 2005000177 W IN2005000177 W IN 2005000177W WO 2005115092 A3 WO2005115092 A3 WO 2005115092A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
oral pharmaceutical
micronized
pharmaceutically acceptable
micronized oral
Prior art date
Application number
PCT/IN2005/000177
Other languages
French (fr)
Other versions
WO2005115092A2 (en
Inventor
Nitin Bhalachand Dharmadhikari
Vaishali Vijay Dhavse
Original Assignee
Sun Pharmaceutical Ind Ltd
Nitin Bhalachand Dharmadhikari
Vaishali Vijay Dhavse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd, Nitin Bhalachand Dharmadhikari, Vaishali Vijay Dhavse filed Critical Sun Pharmaceutical Ind Ltd
Publication of WO2005115092A2 publication Critical patent/WO2005115092A2/en
Publication of WO2005115092A3 publication Critical patent/WO2005115092A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Abstract

An oral pharmaceutical composition comprising isradipine or its pharmaceutically acceptable salt and pharmaceutically acceptable excipients wherein isradipine or its pharmaceutically acceptable salt has a meou particle size of 3,5 mm to 7,5 mm.
PCT/IN2005/000177 2004-05-28 2005-05-30 Micronized oral pharmaceutical composition WO2005115092A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN601MU2004 2004-05-28
IN601/MUM/2004 2004-05-28

Publications (2)

Publication Number Publication Date
WO2005115092A2 WO2005115092A2 (en) 2005-12-08
WO2005115092A3 true WO2005115092A3 (en) 2006-03-23

Family

ID=35451321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2005/000177 WO2005115092A2 (en) 2004-05-28 2005-05-30 Micronized oral pharmaceutical composition

Country Status (1)

Country Link
WO (1) WO2005115092A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020071870A1 (en) * 1999-06-28 2002-06-13 Vinay K. Sharma Preparation of micron-size pharmaceutical particles by microfluidization
US6645528B1 (en) * 1999-05-27 2003-11-11 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645528B1 (en) * 1999-05-27 2003-11-11 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US20020071870A1 (en) * 1999-06-28 2002-06-13 Vinay K. Sharma Preparation of micron-size pharmaceutical particles by microfluidization

Also Published As

Publication number Publication date
WO2005115092A2 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
WO2006128057A3 (en) Oral dosage forms comprising progesterone and methods of making and using the same
AP2012006231A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
WO2009081174A3 (en) Anti - retroviral combination
HK1126671A1 (en) Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
AU2003246978A1 (en) Pharmaceutical compositions comprising cyclosporin for oral administration
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
WO2008062475A3 (en) Pharmaceutical compositions of ursodiol
WO2005004860A3 (en) Novel solid pharmaceutical composition comprising amisulpride
WO2002011694A3 (en) Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
WO2005009407A3 (en) Oral pharmaceutical formulations of olanzapine
TNSN06003A1 (en) Saquinavir mesylate oral dosage form
WO2005123086A3 (en) Ziprasidone dosage form
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
WO2004096125A3 (en) Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
AU2003244259A1 (en) Oral injectable pharmaceutical composition comprising florfenicol as an active ingredient
WO2005115092A3 (en) Micronized oral pharmaceutical composition
WO2007119249A3 (en) Pharmaceutical compositions of cefixime
WO2006136916A3 (en) Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
WO2006123358A3 (en) Stabilized atorvastatin-containing formulation
TW200621304A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase